Secor Capital Advisors’s NeoGenomics NEO Stock Holding History

Secor Capital Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-104,428	Closed	-$1.32M	–	525
2018 Q4	$1.32M	Buy	104,428 +875	+0.8%	+$13K	0.17%	175
2018 Q3	$1.59M	Buy	103,553 +30,302	+41%	+$419K	0.17%	179
2018 Q2	$960K	Sell	73,251 -69,099	-49%	-$760K	0.08%	309
2018 Q1	$1.16M	Buy	+142,350	New	+$1.15M	0.1%	270

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Secor Capital Advisors's NEO Position: Q1 2019 in Review

Secor Capital Advisors sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 104,428 shares — an estimated $1.32M sold.

Secor Capital Advisors first reported a position in NEO in Q1 2018 and held it in 4 quarters. The position peaked at $1.59M in Q3 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

Secor Capital Advisors reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 104,428 NeoGenomics shares in Q1 2019, an estimated $1.32M.
Secor Capital Advisors first reported a position in NeoGenomics in Q1 2018 and held it in 4 quarters.
Secor Capital Advisors's NeoGenomics position peaked at $1.59M in Q3 2018.
235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.